Date: 2015-03-31
Type of information: Private placement
Company: Tiziana Life Sciences (UK)
Investors:
Amount: £2.55 million (€3.48 million)
Funding type: private placement
Planned used:
Others: * On March 31, 2015, Tiziana Life Sciences, a clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announced that the Company has raised £2.55 million through the issue of 3,400,000 new ordinary shares to new investors at a price of 75 pence per share. Application has been made to the London Stock Exchange to admit the Placing Shares to trading on AIM and admission is expected to occur on 7 April 2015. The Placing Shares will rank pari passu with the Company’s existing ordinary shares. Following the issue of the Placing Shares, the enlarged issued share capital of the Company will comprise 92,333,928 ordinary shares of 3p each. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.
Therapeutic area: Cancer - Oncology
